Title:
キナーゼを阻害する組成物及び方法
Document Type and Number:
Japanese Patent JP6795518
Kind Code:
B2
Abstract:
The present invention provides compounds for the prevention or treatment of cancer or a bacterial or viral infection. Additionally, the present invention provides compositions and methods for using these compounds and compositions in the prevention or treatment of cancer or a bacterial or viral infection in a subject.
Inventors:
Warner, Milton, H.
Kelly, Terence, A.
Kelly, Terence, A.
Application Number:
JP2017555374A
Publication Date:
December 02, 2020
Filing Date:
April 22, 2016
Export Citation:
Assignee:
Inhibicase Therapeutics, Incorporated
International Classes:
C07D401/14; A61K31/506; A61K39/395; A61K45/00; A61P31/04; A61P31/12; A61P31/18; A61P31/22; A61P35/00; A61P43/00; C07D413/14; C07D417/14
Domestic Patent References:
| JP2010502726A | ||||
| JP2006527230A |
Foreign References:
| WO2008070350A2 |
Other References:
Napier, R. J. et al.,Low Doses of Imatinib Induce Myelopoiesis and Enhance Host Anti-microbial Immunity,PLOS PATHOGENS,2015年,March 30,pp. 1-27,Retrieved from the internet:
Attorney, Agent or Firm:
Hiraki International Patent Office